Short Interest in China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Drops By 22.1%

China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) was the target of a large decrease in short interest in the month of October. As of October 15th, there was short interest totalling 196,000 shares, a decrease of 22.1% from the September 30th total of 251,600 shares. Based on an average trading volume of 628,200 shares, the short-interest ratio is currently 0.3 days. Approximately 5.7% of the company’s shares are short sold.

China SXT Pharmaceuticals Stock Performance

Shares of NASDAQ SXTC traded down $0.03 during trading on Friday, hitting $0.58. 224,751 shares of the company traded hands, compared to its average volume of 781,362. The company has a quick ratio of 1.51, a current ratio of 1.60 and a debt-to-equity ratio of 0.01. The company has a 50-day moving average price of $0.67 and a 200-day moving average price of $0.95. China SXT Pharmaceuticals has a 1 year low of $0.53 and a 1 year high of $6.39.

China SXT Pharmaceuticals Company Profile

China SXT Pharmaceuticals, Inc, a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.